10x Insights
Loading account…
Companies / Financials / CME Group
CME

CME Group

FinancialsBanks & BrokersS&P 500
Ticker CMECHICAGO, ILFiscal year ends DecemberBook value per share $73.21Diluted shares 362.2M

CME Group Inc. (NASDAQ: CME) operates as a leading global derivatives marketplace and central counterparty clearing provider. The company's website is cmegroup.com. From the company’s description.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$6.52BFY2025
+6.4% year over year
Last 12 mo $6.77B
64.86%FY2025
+0.7 percentage points
Last 12 mo 65.10%
$4.07BFY2025
+15.5% year over year
Last 12 mo $4.29B
14.17%FY2025
+0.9 percentage points
Cash & financing
$4.28BFY2025
+15.9% year over year
Last 12 mo $4.31B
$4.19BFY2025
+16.6% year over year
Last 12 mo $4.21B
0.12FY2025
Was 0.13× a year earlier
Last 12 mo 0.13
360.3MFY2025
+0.1% year over year
Last 12 mo 362.2M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What CME Group does

In the company’s own words

CME Group Inc. (NASDAQ: CME) operates as a leading global derivatives marketplace and central counterparty clearing provider. The company's website is cmegroup.com.

CME Group enables clients worldwide to trade futures, options, cash and over-the-counter products while providing clearing, settlement and market data services. The company operates through its derivatives exchange business, derivatives clearing business, securities clearing business, cash markets business and data services business.

The derivatives exchange business offers the widest range of global benchmark products across interest rates, equity indexes, foreign exchange, and agricultural, energy and metals commodities. Products include SOFR and U.S. Treasury futures, E-mini equity index contracts, major currency pairs and commodity contracts. These products trade primarily through CME Globex, the company's electronic trading platform. In 2025, CME Group futures and options achieved record average daily volume of 28.1 million contracts.

Through its derivatives clearing house operated by CME, the company provides clearing and settlement services for exchange-traded futures and options, exchange-traded swaps and OTC derivatives. The clearing business generated significant revenue from clearing and transaction fees, with one clearing firm representing twelve percent of clearing revenue in 2025.

The cash markets business comprises BrokerTec and EBS, acquired through the NEX acquisition. BrokerTec operates global electronic trading for fixed income and money market products with leading positions in cash U.S. Treasuries, European Government Bonds and repo markets. EBS provides trading of global foreign exchange products and spot precious metals. These cash markets businesses generated $283.7 million in clearing and transaction fees during 2025.

The data services business offers proprietary real-time and historical market data, derived pricing, alternative data sets and analytic tools. CME Group distributes leading benchmark indices and administers CME Term SOFR through its UK-regulated subsidiary, CME Benchmark Administration Limited.

In December 2025, CME Securities Clearing Inc. received SEC approval to become a securities clearing agency, with planned launch of services in 2026 for U.S. Treasury and repo transactions. The company maintains a strategic partnership with Google Cloud to migrate core applications and eventually move trading markets to cloud infrastructure. CME Group's membership base includes professional traders, financial institutions, corporations, governments and central banks globally.

Company details
Sector
Financials
Industry (SIC)
Banks & Brokers
Headquarters
CHICAGO, IL
Fiscal year end
December
CIK
1156375
SIC
6200

Financial performance, year by year

Fiscal 2013–2025 · USD
$-677.26M$1.35B$3.39B$5.42B$7.45B2013201420152016201720182019202020212022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns CME Group — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

940
funds hold it
2 of 35
superinvestors hold it
$27.01B
held by funds, at market
30.4%
of shares held by funds
5
bond issues held by funds

Superinvestors in CME Group · what they did last quarter

Seth KlarmanNEW
Baupost Group
2.5%of 13F portfolio
Tom GaynerUNCHANGED
Markel Group (Markel-Gayner)
0.1%of 13F portfolio

Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.

Largest fund holders · CME Group’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.11%of fund net assets
VANGUARD 500 INDEX FUND
VOO · VANGUARD INDEX FUNDS
0.12%of fund net assets
Fidelity 500 Index Fund
FXAIX · Fidelity Concord Street Trust
0.15%of fund net assets
—of fund net assets
iShares Core S&P 500 ETF
IVV · iShares Trust
0.12%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

CME Group’s bonds, as funds hold them

Funds report holding 5 issues of CME Group’s debt, $312.35M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 4.00%, maturing 2028 to 2048.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do CME Group and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of CME Group's earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in CME Group's last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.